- Home
- OPK vs REAL Comparison
OPK vs REAL Comparison
Compare OPK & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- REAL
- Stock Information
- Founded
- OPK 2007
- REAL 2011
- Country
- OPK United States
- REAL United States
- Employees
- OPK N/A
- REAL N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- REAL Other Specialty Stores
- Sector
- OPK Health Care
- REAL Consumer Discretionary
- Exchange
- OPK Nasdaq
- REAL Nasdaq
- Market Cap
- OPK 1.0B
- REAL 871.2M
- IPO Year
- OPK 1995
- REAL 2019
- Fundamental
- Price
- OPK $1.38
- REAL $10.00
- Analyst Decision
- OPK Buy
- REAL Strong Buy
- Analyst Count
- OPK 4
- REAL 5
- Target Price
- OPK $2.75
- REAL $11.70
- AVG Volume (30 Days)
- OPK 1.9M
- REAL 4.0M
- Earning Date
- OPK 11-06-2025
- REAL 11-03-2025
- Dividend Yield
- OPK N/A
- REAL N/A
- EPS Growth
- OPK N/A
- REAL N/A
- EPS
- OPK N/A
- REAL N/A
- Revenue
- OPK $664,029,000.00
- REAL $636,971,000.00
- Revenue This Year
- OPK N/A
- REAL $14.27
- Revenue Next Year
- OPK $0.84
- REAL $9.94
- P/E Ratio
- OPK N/A
- REAL N/A
- Revenue Growth
- OPK N/A
- REAL 12.68
- 52 Week Low
- OPK $1.11
- REAL $2.71
- 52 Week High
- OPK $2.04
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- OPK 50.29
- REAL 77.08
- Support Level
- OPK $1.34
- REAL $8.02
- Resistance Level
- OPK $1.44
- REAL $8.86
- Average True Range (ATR)
- OPK 0.04
- REAL 0.47
- MACD
- OPK -0.00
- REAL 0.12
- Stochastic Oscillator
- OPK 40.00
- REAL 88.85
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.